Objective: Multidrug-resistant organisms (MDROs) are continually emerging and threatening health care systems. Little attention has been paid to the effect of patient transfers on MDRO dissemination among health care entities in health care systems. In this study, the Florida Department of Health in Orange County (DOH-Orange) developed a baseline social network analysis of patient movement across health care entities in Orange County, Florida, and regionally, within 6 surrounding counties in Central Florida. Materials and Methods: DOH-Orange constructed 2 directed network sociograms—graphic visualizations that show the direction of relationships (ie, county and regional)—by using 2016 health insurance data from the Centers for Medicare & Medicaid Services, which include metrics that could be useful for local public health interventions, such as MDRO outbreaks. Results: We found that both our county and regional networks were sparse and centralized. The county-level network showed that acute-care hospitals had the highest influence on controlling the flow of patients between health care entities that would otherwise not be connected. The regional-level network showed that post–acute-care hospitals and other facilities (behavioral hospitals and mental health/substance abuse facilities) served as the primary controls for flow of patients between health care entities. The most prominent health care entities in both networks were the same 2 acute-care hospitals. Practice Implications: Social network analysis can help local public health officials respond to MDRO outbreak investigations by determining which health care facilities are the main contributors of dissemination of MDROs or are at high risk of receiving patients with MDROs. This information can help epidemiologists prioritize prevention efforts and develop county- or regional-specific interventions to control and halt MDRO transmission across a health care network.
Introduction: This study addresses critical gaps in public health workforce development, focusing on data science and leadership skills amidst increasing data accessibility and complexity in public health practice.Methods: Quantitative and qualitative research methods were employed, including listening sessions with diverse public health professionals. Recruitment and post-session surveys were conducted, and session transcripts were analyzed using phenomenological and categorical coding methods based on the PPP Framework.Results: The research identified three core concepts in public health data science and leadership: data science, data literacy, and data-informed leadership. Clear definitions for each concept were developed. Significant gaps in workforce capacity, accessibility, and training were highlighted, particularly in aligning academic curricula with real-world public health needs.Analysis: The study revealed a disconnect between current public health programs and workforce preparedness, performance, and practice. Participants emphasized the need for comprehensive leadership development programs and integration of data science and leadership components into existing curricula.Discussion: This work provides a foundation for strengthening the public health workforce by identifying key concepts and gaps in data science and leadership. The findings have implications for policy development, resource allocation, and building a competent workforce capable of leveraging data for improved public health outcomes. This research contributes to advancing the field of public health by communicating scientific knowledge crucial for future breakthroughs in workforce development.
With social networking enabling the expressions of billions of people to be posted online, sentiment analysis and massive computational power enables systematic mining of information about populations including their affective states with respect to epidemiological concerns during a pandemic. Gleaning rationale for behavioral choices, such as vaccine hesitancy, from public commentary expressed through social media channels may provide quantifiable and articulated sources of feedback that are useful for rapidly modifying or refining pandemic spread predictions, health protocols, vaccination offerings, and policy approaches. Additional potential gains of sentiment analysis may include lessening of vaccine hesitancy, reduction in civil disobedience, and most importantly, better healthcare outcomes for individuals and their communities. In this article, we highlight the evolution of select epidemiological models; conduct a critical review of models in terms of the level and depth of modeling of social media, social network factors, and sentiment analysis; and finally, partially illustrate sentiment analysis using COVID-19 Twitter data.
1 January 2021 in Health Services Research and Managerial Epidemiology
The sentiment analysis of social media for predicting behavior during a pandemic is seminal in nature. As an applied contribution, we present sentiment-based regression models for predicting the United States COVID-19 first dose, second dose, and booster daily inoculations from 1 June 2021 to 31 March 2022. The models merge independent variables representing fear of the virus and vaccine hesitancy. Large correlations exceeding 77% and 84% for the first-dose and booster-dose models inspire confidence in the merger of the independent variables. Death count as a traditional measure of fear is a lagging indicator of inoculations, while Twitter-positive and -negative tweets are strong predictors of inoculations. Thus, the use of sentiment analysis for predicting inoculations is strongly supported with administrative events being catalysts for tweets. Non-inclusion in the second-dose regression model of data occurring before the 1 June 2021 timeframe appear to limit the second-dose model results—only achieving a moderate correlation exceeding 53%. Limiting tweet collection to geolocated tweets does not encompass the entire US Twitter population. Nonetheless, results from Kaiser Family Foundation (KFF) surveys appear to generally support the regression factors common to the first-dose and booster-dose regression models and their results.